Latest Sustainability News

Northern Star Resources delivered record underlying free cash flow in FY25 and is advancing its KCGM Mill Expansion into the final build year, positioning the company for growth in FY26 and beyond.

Cyclone Metals reports strong progress on its Iron Bear Project, highlighting a completed renewable energy power study and successful metallurgical test results that underpin its sustainable mining ambitions.

Civmec Limited has announced a series of new contracts and extensions valued at more than A$600 million, including the integration of the SEA1180 maritime defence program following its acquisition of Luerssen Australia. The company is also advancing major infrastructure and green energy projects, signaling robust growth and diversification.

Hillgrove Resources outlined its operational progress and growth strategy at the Noosa Mining Investor Conference, highlighting strong cash flow and resource expansion at its Kanmantoo Copper Gold Mine.

Raptis Group Limited has confirmed that director James Raptis will resign effective 30 September 2025, affirming the company’s compliance with ASX continuous disclosure rules.

Macarthur Minerals has clarified the timing of its entitlement offer, confirming the securities issue date as 7 August 2025 with ASX quotation expected the following day. The company also reaffirmed its substantial iron ore resources at Lake Giles, maintaining investor confidence ahead of the capital raise.

Ardea Resources is progressing its Kalgoorlie Nickel Project with a fully funded Definitive Feasibility Study by Sumitomo Metal Mining and Mitsubishi Corporation, aiming to deliver a long-life, low-cost nickel-cobalt supply from Australia’s largest resource.

Spheria Emerging Companies Limited has announced its highest-ever quarterly dividend of 3.6 cents per share, fully franked and payable in August 2025, reflecting strong long-term portfolio returns despite recent market volatility.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

IperionX has successfully commissioned its Virginia titanium manufacturing campus, secured a substantial U.S. Department of Defense contract, and raised $46 million to fast-track production expansion through 2030.

Lake Resources has raised $2.1 million through its At-the-Market facility by issuing 65 million shares to Acuity Capital, while extending the agreement to 2031 to support its Kachi Project and working capital needs.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.